GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's change in working capital for the quarter that ended in Mar. 2015 was $1.73 Mil. It means Synageva BioPharma Corp's working capital increased by $1.73 Mil from Dec. 2014 to Mar. 2015 .
Synageva BioPharma Corp's change in working capital for the fiscal year that ended in Dec. 2014 was $8.22 Mil. It means Synageva BioPharma Corp's working capital increased by $8.22 Mil from Dec. 2013 to Dec. 2014 .
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.
Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.
Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC
|Consolidated Statements of Cash Flows||Fiscal Years Ended||January 31,||(Amounts in millions)|
|Cash flows from operating activities:||2014||2013||2012|
|Changes in certain assets and liabilities, net of effects of acquisitions:|
|Accrued income taxes||(1,224)||981||994|
For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data